A study has found that restorative neurostimulation continues to be effective in treating low-back pain caused by multifidus dysfunction after three years. This type of dysfunction occurs when the ...

A new study in mice, carried out by researchers at Heidelberg University Medical Faculty Heidelberg, has helped illuminate how the brain’s primary motor cortex (a region known as M1) helps to suppress ...

St. Jude Medical has received FDA clearance for its Epiducer neurostimulation lead delivery system for pain management, according to a company news release. The Epiducer system allows placement of as ...

Chronic pain is pain that persists for longer than expected for the typical illness or injury or for more than 3 to 6 months. The most common causes are low back pain, headache, neck pain and face ...

DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc today announced the publication of data from a single center, real-world study with one-year clinical follow-up of patients selected from the ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical Inc. (“Nalu”) revealed significant findings from a landmark clinical trial evaluating the Nalu Peripheral Nerve Stimulation (PNS) System utilizing their ...

FLORIDA — LIVING WITH PAIN: Millions of people suffer from chronic pain on a daily basis, experiencing exactly how disruptive and destructive it can be. An estimated 26 million Americans between the ...

South Florida pain clinic, Berkower Pain & Spine, is now offering the P-Stim neurostimulator treatment. This amazing low risk, outpatient, FDA approved treatment has no known side effects and may ...

) today announced the U.S. Food and Drug Administration (FDA) clearance and limited market release of the Epiducer™ lead delivery system for neurostimulation therapy. This first-of-its-kind system ...

17-year-old LanDanOlivia appears to be a typical teenager who enjoys visiting theme parks, going to the beach, skimboarding and spending time with friends. But her life has been anything but typical.

Request To Download Free Sample of This Strategic Report @ Market Overview In 2018, the global neurostimulation devices market exhibited a valuation of $4,387.5 million, marking the inception of a ...